
Julie Ha
Examiner (ID: 17647, Phone: (571)272-5982 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675 |
| Total Applications | 1488 |
| Issued Applications | 934 |
| Pending Applications | 118 |
| Abandoned Applications | 454 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17226988
[patent_doc_number] => 20210353544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS FOR CRYSTALLINE MICROPARTICLE SURFACES
[patent_app_type] => utility
[patent_app_number] => 17/443344
[patent_app_country] => US
[patent_app_date] => 2021-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17443344
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/443344 | METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS FOR CRYSTALLINE MICROPARTICLE SURFACES | Jul 25, 2021 | Abandoned |
Array
(
[id] => 18597235
[patent_doc_number] => 20230272029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => CO-AGONISTS AT GLP-1 AND GIP RECEPTORS SUITABLE FOR ORAL DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/017041
[patent_app_country] => US
[patent_app_date] => 2021-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15364
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017041
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017041 | CO-AGONISTS AT GLP-1 AND GIP RECEPTORS SUITABLE FOR ORAL DELIVERY | Jul 21, 2021 | Pending |
Array
(
[id] => 18724331
[patent_doc_number] => 20230338469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => METHOD OF ENCAPSULATION OF AN ACTIVE PROTEIN USING ELECTRODEPOSITION TECHNIQUES, AN ANTIBACTERIAL COMPOSITION CONTAINING THE ACTIVE PROTEIN AND A POLYMER, AND ITS USE FOR THE PRODUCTION OF MEDICATIONS INTENDED FOR HUMANS
[patent_app_type] => utility
[patent_app_number] => 18/005052
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005052
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005052 | METHOD OF ENCAPSULATION OF AN ACTIVE PROTEIN USING ELECTRODEPOSITION TECHNIQUES, AN ANTIBACTERIAL COMPOSITION CONTAINING THE ACTIVE PROTEIN AND A POLYMER, AND ITS USE FOR THE PRODUCTION OF MEDICATIONS INTENDED FOR HUMANS | Jul 7, 2021 | Abandoned |
Array
(
[id] => 17342171
[patent_doc_number] => 20220008502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => Method to Treat Alzheimer`s Disease
[patent_app_type] => utility
[patent_app_number] => 17/369681
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17369681
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/369681 | Method to treat Alzheimer's disease | Jul 6, 2021 | Issued |
Array
(
[id] => 18565725
[patent_doc_number] => 20230256052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => METHOD AND COMPOSITION FOR REDUCING OR PREVENTING BONE RESORPTION
[patent_app_type] => utility
[patent_app_number] => 18/012288
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8539
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18012288
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/012288 | METHOD AND COMPOSITION FOR REDUCING OR PREVENTING BONE RESORPTION | Jul 6, 2021 | Pending |
Array
(
[id] => 18550631
[patent_doc_number] => 20230248631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => FRAGRANCE RELEASE MECHANISM, METHOD AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/003127
[patent_app_country] => US
[patent_app_date] => 2021-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003127
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/003127 | FRAGRANCE RELEASE MECHANISM, METHOD AND USES THEREOF | Jul 4, 2021 | Pending |
Array
(
[id] => 17336015
[patent_doc_number] => 20220002346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => PEPTIDE-PEPTOID SCAFFOLDS
[patent_app_type] => utility
[patent_app_number] => 17/366822
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8886
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17366822
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/366822 | Peptide-peptoid scaffolds | Jul 1, 2021 | Issued |
Array
(
[id] => 17299468
[patent_doc_number] => 20210395307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => PEPTIDE THAT REGULATES FAT METABOLISM AND METHOD FOR REGULATING FAT METABOLISM
[patent_app_type] => utility
[patent_app_number] => 17/359370
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 361
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17359370
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/359370 | Peptide that regulates fat metabolism and method for regulating fat metabolism | Jun 24, 2021 | Issued |
Array
(
[id] => 19242021
[patent_doc_number] => 12012440
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-18
[patent_title] => Compositions and methods for treatment of fungal infections
[patent_app_type] => utility
[patent_app_number] => 17/358828
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 7006
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17358828
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/358828 | Compositions and methods for treatment of fungal infections | Jun 24, 2021 | Issued |
Array
(
[id] => 17814330
[patent_doc_number] => 11419919
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-08-23
[patent_title] => High-purity adrenocorticotropic hormone, analogue and a large-scale preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 17/357255
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8330
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17357255
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/357255 | High-purity adrenocorticotropic hormone, analogue and a large-scale preparation method thereof | Jun 23, 2021 | Issued |
Array
(
[id] => 18860267
[patent_doc_number] => 20230414701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING COGNITIVE DYSFUNCTION DISEASE, COMPRISING PEPTIDE HAVING SYNAPTIC PLASTICITY CONTROL FUNCTION
[patent_app_type] => utility
[patent_app_number] => 18/011363
[patent_app_country] => US
[patent_app_date] => 2021-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011363
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011363 | COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING COGNITIVE DYSFUNCTION DISEASE, COMPRISING PEPTIDE HAVING SYNAPTIC PLASTICITY CONTROL FUNCTION | Jun 17, 2021 | Pending |
Array
(
[id] => 17156115
[patent_doc_number] => 20210317166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => ANTI-INFLAMMATORY USE OF PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 17/350795
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17350795
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/350795 | Anti-inflammatory use of peptide | Jun 16, 2021 | Issued |
Array
(
[id] => 19431062
[patent_doc_number] => 20240299560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => DEOXYCHOLIC ACID-PEPTIDE CONJUGATE HAVING ANTI-OBESITY ACTIVITY AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/009418
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009418
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009418 | DEOXYCHOLIC ACID-PEPTIDE CONJUGATE HAVING ANTI-OBESITY ACTIVITY AND USE THEREOF | Jun 10, 2021 | Pending |
Array
(
[id] => 17895269
[patent_doc_number] => 20220304931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => COMPOSITION FOR PROMOTING EXTRACELLULAR VESICLE PRODUCTION CONTAINING PEPTIDE DERIVED FROM NOXA PROTEIN AND METHOD FOR PRODUCING EXTRACELLULAR VESICLES BY USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/424232
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17424232
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/424232 | Composition for promoting extracellular vesicle production containing peptide derived from noxa protein and method for producing extracellular vesicles by using same | Jun 2, 2021 | Issued |
Array
(
[id] => 18375975
[patent_doc_number] => 20230151057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => LACTIC ACID BACTERIA GROWTH PROMOTER
[patent_app_type] => utility
[patent_app_number] => 17/920598
[patent_app_country] => US
[patent_app_date] => 2021-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17920598
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/920598 | LACTIC ACID BACTERIA GROWTH PROMOTER | May 31, 2021 | Pending |
Array
(
[id] => 18626771
[patent_doc_number] => 20230285578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => PTH ANALOGS FOR THE TREATMENT OF HYPOPARATHYROIDISM
[patent_app_type] => utility
[patent_app_number] => 17/925477
[patent_app_country] => US
[patent_app_date] => 2021-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/925477 | PTH ANALOGS FOR THE TREATMENT OF HYPOPARATHYROIDISM | May 24, 2021 | Pending |
Array
(
[id] => 18643285
[patent_doc_number] => 11767345
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Antiviral peptide and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/329418
[patent_app_country] => US
[patent_app_date] => 2021-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 7953
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17329418
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/329418 | Antiviral peptide and use thereof | May 24, 2021 | Issued |
Array
(
[id] => 18536014
[patent_doc_number] => 20230241101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => THERAPEUTIC COMPOSITION AND METHOD FOR TREATING CORONAVIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/927390
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17927390
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/927390 | THERAPEUTIC COMPOSITION AND METHOD FOR TREATING CORONAVIRUS INFECTION | May 19, 2021 | Abandoned |
Array
(
[id] => 17241810
[patent_doc_number] => 20210361553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => SKIN CARE PRODUCT WITH PROTEIN MATRIX
[patent_app_type] => utility
[patent_app_number] => 17/323421
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17323421
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/323421 | Skin care product with protein matrix | May 17, 2021 | Issued |
Array
(
[id] => 18752460
[patent_doc_number] => 20230355711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => VIMENTIN AND FRAGMENTS OR DERIVATIVES THEREOF FOR CORONAVIRUS TREATMENT AND PREVENTION
[patent_app_type] => utility
[patent_app_number] => 17/998237
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998237
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998237 | VIMENTIN AND FRAGMENTS OR DERIVATIVES THEREOF FOR CORONAVIRUS TREATMENT AND PREVENTION | May 13, 2021 | Abandoned |